Loading…

Nitric oxide-dependent biodegradation of graphene oxide reduces inflammation in the gastrointestinal tract

Understanding the biological fate of graphene-based materials such as graphene oxide (GO) is crucial to assess adverse effects following intentional or inadvertent exposure. Here we provide first evidence of biodegradation of GO in the gastrointestinal tract using zebrafish as a model. Raman mapping...

Full description

Saved in:
Bibliographic Details
Published in:Nanoscale 2020-08, Vol.12 (32), p.1673-16737
Main Authors: Peng, Guotao, Montenegro, Marcelo F, Ntola, Chifundo N. M, Vranic, Sandra, Kostarelos, Kostas, Vogt, Carmen, Toprak, Muhammet S, Duan, Tianbo, Leifer, Klaus, Bräutigam, Lars, Lundberg, Jon O, Fadeel, Bengt
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Understanding the biological fate of graphene-based materials such as graphene oxide (GO) is crucial to assess adverse effects following intentional or inadvertent exposure. Here we provide first evidence of biodegradation of GO in the gastrointestinal tract using zebrafish as a model. Raman mapping was deployed to assess biodegradation. The degradation was blocked upon knockdown of nos2a encoding the inducible nitric oxide synthase (iNOS) or by pharmacological inhibition of NOS using l -NAME, demonstrating that the process was nitric oxide (NO)-dependent. NO-dependent degradation of GO was further confirmed in vitro by combining a superoxide-generating system, xanthine/xanthine oxidase (X/XO), with an NO donor (PAPA NONOate), or by simultaneously producing superoxide and NO by decomposition of SIN-1. Finally, by using the transgenic strain Tg ( mpx :eGFP) to visualize the movement of neutrophils, we could show that inhibition of the degradation of GO resulted in increased neutrophil infiltration into the gastrointestinal tract, indicative of inflammation. Graphene oxide (GO) undergoes nitric oxide (NO)-dependent degradation leading to reduced infiltration of polymorphonuclear cells (PMNs) in the GI tract.
ISSN:2040-3364
2040-3372
2040-3372
DOI:10.1039/d0nr03675g